secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANNKIND CORP (MNKD)
CIK:        0000899460
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001193125-25-120797
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

MannKind Chief Medical Officer Burkhard Blank to depart; separation terms include $386K bonus
--------------------------------------------------------------------------------

- Burkhard Blank stepped down as CMO and EVP R&D effective May 9, 2025, becoming non-executive employee.
- Last day of employment is August 1, 2025; base salary continued for 13 weeks through Oct 31, 2025.
- One-time special bonus of $386,000 payable in January 2026; COBRA premiums reimbursed until Oct 31.
- Equity awards continue to vest while Blank remains employed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899460/000119312525120797/0001193125-25-120797-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899460/000119312525120797/d915656d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-120797

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer